Patent
Clinical diagnosis of hepatic fibrosis using human serum APOL1 as biomarker
- Alternative title:
- European Patent Office patent EP2469283 (A1)
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Publisher:
- European Patent Office Publisher's website
- Publication date:
- 2012-06-27
- Patent status:
- Issued/granted
- Patent number:
-
EP2469283
- Application number:
- 11174936
- Source identifiers:
-
383417
Item Description
- Documentation:
-
The inventors have proposed a novel panel of human serum protein biomarkers for diagnosing hepatic fibrosis and cirrhosis. Presently there is no reliable non-invasive way of assessing liver fibrosis. A 2D-PAGE based proteomics study was used to identify potential fibrosis biomarkers. Serum from patients with varying degrees of hepatic scarring induced by infection with the hepatitis C virus (HCV) was analysed. Several proteins associated with liver scarring and/or viral infection were identif... Expand documentation
- Pubs id:
-
pubs:383417
- UUID:
-
uuid:477936a8-6b33-4ecf-8826-49e10a8c8082
- Local pid:
- pubs:383417
- Deposit date:
- 2016-02-04
Terms of use
- Copyright date:
- 2012
If you are the owner of this record, you can report an update to it here: Report update to this record